From his low-security prison in Pennsylvania, former pharmaceutical executive and so-called “Pharma Bro” Martin Shkreli this week continued to seek a reduction in his sentence, arguing that his confinement prevents him from mounting an effective defense in a “fast-paced and complex” civil suit brought by the Federal Trade Commission.

In a reply letter to U.S. District Judge Kiyo Matsumoto Thursday, Shkreli’s attorney, Benjamin Brafman of Brafman & Associates, argued that “[t]here is no accommodation that the BOP can safely put into place that will result in Mr. Shkreli having sufficient access to Civil Counsel” in the FTC case.